Safety of Telaprevir Treatment in Asian-American Adults with Genotype 1 Chronic Hepatitis C Virus Infection

被引：0
|
作者：
Pan, Calvin [1 ]
Zeng, Zheng [2 ]
Ouyang, Elsa [3 ]
机构：
[1] NYU Sch Med, NYU Langone Med Ctr, Div Gastroenterol & Hepatol, Flushing, NY USA
[2] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[3] St Johns Univ, Jamaica, NY 11439 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-00479
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
479
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [21] Simeprevir for the treatment of chronic hepatitis C genotype 1 infection
    Takehara, Tetsuo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (08) : 909 - 917
  • [22] Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis
    Dang, Shuang-Suo
    Wang, Wen-Jun
    Wang, Xiu-Fang
    Li, Ya-Ping
    Li, Mei
    Jia, Xiao-Li
    Wang, Yuan
    Liu, Enqi
    Zhao, Sihai
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 461 - 468
  • [23] SAFETY AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR IN ADULTS WITH CHRONIC HEPATITIS C VIRUS INFECTION GENOTYPE 1 AND 6 AND CHRONIC KIDNEY DISEASE: AN INTEGRATED ANALYSIS
    Pol, Stanislas
    Pockros, Paul J.
    Pugatch, David
    Brau, Norbert
    Landis, Charles
    Elkhashab, Magdy
    Sasadeusz, Joe
    Tran, Albert
    Hu, Yiran
    Kosloski, Matthew P.
    Mensa, Federico
    GASTROENTEROLOGY, 2017, 152 (05) : S1062 - S1063
  • [24] Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis
    Qu, Yundong
    Li, Tao
    Wang, Lei
    Liu, Feng
    Ye, Qian
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (02) : 203 - 212
  • [25] Safety of Telaprevir for Chronic Hepatitis C Virus Infection A Meta-Analysis of Randomized Controlled Trials
    Qin, Huimin
    Li, Hongtao
    Zhou, Xiaolin
    Feng, Fang
    Shen, Yanbing
    Tan, Hongku
    Ye, Feng
    Xie, Yingchun
    CLINICAL DRUG INVESTIGATION, 2012, 32 (10) : 665 - 672
  • [26] Work productivity among treatment-naive patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment
    Aggarwal, J.
    Vera-Llonch, M.
    Donepudi, M.
    Suthoff, E.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (01) : 8 - 17
  • [27] EFFICACY AND SAFETY OF SOFOSBUVIR-BASED REGIMENS IN A NATIONAL COHORT OF ASIAN-AMERICAN PATIENTS WITH CHRONIC HEPATITIS C
    Pan, Calvin Q.
    Tiongson, Benjamin
    Hu, Ke-Qin
    Tong, Myron J.
    Chu, Danny
    Park, James
    Bhamidimarri, Kalyan R.
    Ma, Xiaoli
    Lee, Tai-Ping
    Xiao, Pei Ying
    Wang, Dan
    GASTROENTEROLOGY, 2017, 152 (05) : S1098 - S1098
  • [28] Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
    Gentile, I.
    Viola, C.
    Borgia, F.
    Castaldo, G.
    Borgia, G.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (09) : 1115 - 1121
  • [29] Safety and efficacy of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection genotype 1-6 and chronic kidney disease: an integrated analysis
    Pol, S.
    Pockros, P.
    Pugatch, D.
    Brau, N.
    Landis, C.
    Elkhashab, M.
    Sasadeusz, J.
    Tran, A.
    Hu, Y.
    Kosloski, M.
    Mensa, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S738 - S738
  • [30] Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype I infection: an indirect comparison meta-analysis
    Cooper, Curtis L.
    Druyts, Eric
    Thorlund, Kristian
    Nachega, Jean B.
    El Khoury, Antoine C.
    O'Regan, Christopher
    Mills, Edward J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 105 - 130
12345